Literature DB >> 16985572

Tissue microarrays in prostate cancer research.

Masood A Khan, Alan W Partin.   

Abstract

Entities:  

Year:  2004        PMID： 16985572      PMCID： PMC1472679     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  11 in total

1.  Inadequate formalin fixation decreases reliability of p27 immunohistochemical staining: probing optimal fixation time using high-density tissue microarrays.

Authors:  Angelo M De Marzo; Helen H Fedor; Wesely R Gage; Mark A Rubin
Journal:  Hum Pathol       Date:  2002-07       Impact factor: 3.466

2.  p53 and bcl-2 immunohistochemistry in preoperative biopsies as predictors of biochemical recurrence after radical prostatectomy.

Authors:  J D Oxley; M H Winkler; K Parry; S Brewster; C Abbott; D A Gillatt
Journal:  BJU Int       Date:  2002-01       Impact factor: 5.588

3.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

Authors:  J Gerdes; H Lemke; H Baisch; H H Wacker; U Schwab; H Stein
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

4.  Low p27 expression predicts poor disease-free survival in patients with prostate cancer.

Authors:  R M Yang; J Naitoh; M Murphy; H J Wang; J Phillipson; J B deKernion; M Loda; R E Reiter
Journal:  J Urol       Date:  1998-03       Impact factor: 7.450

5.  p53 and bcl-2 immunohistochemistry in pretreatment prostate needle biopsies to predict recurrence of prostate cancer after radical prostatectomy.

Authors:  G B Stackhouse; I A Sesterhenn; J J Bauer; F K Mostofi; R R Connelly; S K Srivastava; J W Moul
Journal:  J Urol       Date:  1999-12       Impact factor: 7.450

6.  Expression of p53 and bcl-2 in clinically localized prostate cancer before and after neo-adjuvant hormonal therapy.

Authors:  A M Cesinaro; M Migaldi; G Ferrari; G Castagnetti; A Dotti; C De Gaetani; P Ferrari; G P Trentini
Journal:  Oncol Res       Date:  2000       Impact factor: 5.574

7.  Tissue microarray sampling strategy for prostate cancer biomarker analysis.

Authors:  Mark A Rubin; Rodney Dunn; Myla Strawderman; Kenneth J Pienta
Journal:  Am J Surg Pathol       Date:  2002-03       Impact factor: 6.394

8.  Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.

Authors:  Y Guo; G N Sklar; A Borkowski; N Kyprianou
Journal:  Clin Cancer Res       Date:  1997-12       Impact factor: 12.531

9.  Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma.

Authors:  R J Cote; Y Shi; S Groshen; A C Feng; C Cordon-Cardo; D Skinner; G Lieskovosky
Journal:  J Natl Cancer Inst       Date:  1998-06-17       Impact factor: 13.506

10.  Tissue microarrays for high-throughput molecular profiling of tumor specimens.

Authors:  J Kononen; L Bubendorf; A Kallioniemi; M Bärlund; P Schraml; S Leighton; J Torhorst; M J Mihatsch; G Sauter; O P Kallioniemi
Journal:  Nat Med       Date:  1998-07       Impact factor: 53.440
View more
  2 in total

Review 1.  Emerging critical role of molecular testing in diagnostic genitourinary pathology.

Authors:  George J Netto; Liang Cheng
Journal:  Arch Pathol Lab Med       Date:  2012-04       Impact factor: 5.534

2.  An analysis of a multiple biomarker panel to better predict prostate cancer metastasis after radical prostatectomy.

Authors:  Alison Y Zhang; Karen Chiam; Ygal Haupt; Stephen Fox; Simone Birch; Wayne Tilley; Lisa M Butler; Karen Knudsen; Clay Comstock; Krishan Rasiah; Judith Grogan; Kate L Mahon; Tina Bianco-Miotto; Carmela Ricciardelli; Maret Böhm; Susan Henshall; Warick Delprado; Phillip Stricker; Lisa G Horvath; James G Kench
Journal:  Int J Cancer       Date:  2018-12-04       Impact factor: 7.396
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.